
The combination of FUZEON and boosted darunavir has been shown to give treatment-experienced patients a better chance of achieving an undetectable viral load than boosted darunavir without FUZEON.
Darunavir is also known by the investigational compound number TMC114.
Tibotec Pharmaceuticals Ltd., based in Cork, Ireland, is a division of Janssen-Cilag.
Source: Tibotec Pharmaceuticals






Comment Preview